Insider: GOLDSTEIN JOSEPH L Director - REGENERON PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 6,382 | 0 | 6,382 |
| Value | $4,862,126.70 | $0.00 | $4,862,126.70 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/23/2024 | DDS | 2,707 | Direct | COM | $950.00 | $2,571,650.00 | 6,382 |
| 02/06/2023 | DDS | 3,613 | Direct | COM | $800.00 | $2,890,400.00 | 6,247 |
| 03/30/2022 | DDS | 2,431 | Direct | COM | $700.00 | $1,701,700.00 | 6,082 |
| 09/10/2021 | DDS | 2,479 | Direct | COM | $650.00 | $1,611,350.00 | 5,891 |
| 10/05/2020 | DDS | 9,212 | Direct | COM | $600.00 | $5,527,200.00 | 5,643 |
| 09/22/2020 | DDS | 20 | Direct | COM | $552.36 | $11,047.20 | 5,643 |
| 09/21/2020 | DDS | 1,356 | Direct | COM | $547.28 | $742,111.68 | 19,061 |
| 09/21/2020 | DDS | 800 | Direct | COM | $546.01 | $436,808.00 | 20,417 |
| 09/21/2020 | DDS | 700 | Direct | COM | $544.96 | $381,472.00 | 21,217 |
| 09/21/2020 | DDS | 300 | Direct | COM | $543.19 | $162,957.00 | 21,917 |
| 09/21/2020 | DDS | 2,600 | Direct | COM | $549.07 | $1,427,582.00 | 12,807 |
| 09/21/2020 | DDS | 3,654 | Direct | COM | $548.13 | $2,002,867.02 | 15,407 |
| 09/21/2020 | DDS | 1,600 | Direct | COM | $550.11 | $880,176.00 | 11,207 |
| 09/21/2020 | DDS | 1,530 | Direct | COM | $555.74 | $850,282.20 | 5,663 |
| 09/21/2020 | DDS | 1,101 | Direct | COM | $553.17 | $609,040.17 | 8,092 |
| 09/21/2020 | DDS | 899 | Direct | COM | $554.82 | $498,783.18 | 7,193 |
| 09/21/2020 | DDS | 513 | Direct | COM | $552.01 | $283,181.13 | 9,193 |
| 09/21/2020 | DDS | 1,501 | Direct | COM | $551.09 | $827,186.09 | 9,706 |
| 08/21/2020 | DDS | 1,000 | Direct | COM | $617.18 | $617,180.00 | 5,643 |
| 06/08/2020 | DDS | 100 | Direct | COM | $590.47 | $59,047.00 | 12,006 |
| 06/08/2020 | DDS | 3,200 | Direct | COM | $587.88 | $1,881,216.00 | 12,306 |
| 06/08/2020 | DDS | 200 | Direct | COM | $589.87 | $117,974.00 | 12,106 |
| 06/08/2020 | DDS | 300 | Direct | COM | $587.20 | $176,160.00 | 15,506 |
| 06/08/2020 | DDS | 100 | Direct | COM | $580.65 | $58,065.00 | 17,381 |
| 06/08/2020 | DDS | 60 | Direct | COM | $592.46 | $35,547.60 | 11,946 |
| 1 2 3 4 5 6 Next Last You are at page 1 of 6 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research